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Aim: The aim of this study was to compare the symp-
tomatic and clinical features of depression among
five groups of patients with major depressive disorder
(MDD) living in China, Korea, Malaysia/Singapore,
Taiwan, and Thailand.
Methods: Consecutive consenting adults (aged 18–
65) whomet DSM-IV criteria for non-psychotic MDD
– based on the Mini International Neuropsychiatric
Interview – and who were free of psychotropic medi-
cation were evaluated in a cross-sectional study.
Depressive symptoms were evaluated using the 10-
item Montgomery–Asberg Depression Rating Scale
(MADRS) and the 13-item depression subscale of the
Symptoms Checklist 90-Revised (SCL-90-R). In addi-
tion, the 10-item SCL-90-R Anxiety Subscale was com-
pleted. ANCOVA were conducted, adjusting for con-
founders: age, completion of secondary education,
marital status, work status, religion, index episode
duration, and depressive severity. For the magnitude
of differences, a threshold of 0.10 was taken as the
minimumeffect size representing clinical significance,
and an effect size of 0.25 was considered moderate.
Results: Four MADRS symptoms differentiated these
five groups, the most prominent being ‘lassitude’ and
‘inner tension’. Nine SCL-90-R depression items also
differentiated the groups, as did eight SCL-90-R
Anxiety Subscale items. The MADRS lassitude item
had the largest effect size (0.131). The rest of those
statistically significant differences did not exceed 0.10.
Conclusion: MDD is more similar than different
among outpatients in these diverse Asian countries.
The between-country differences, while present and
not due to chance, are small enough to enable the use
of common clinician and self-report rating scales in
studies involving Asians with MDD from various
ethnic backgrounds.
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DEPRESSIVE DISORDERS ARE a major publichealth problem in most countries. In 2004, the
World Health Organization estimated that approxi-
mately 151 million people across the world suffer
from unipolar depressive disorder, of which 80
million live in South-East Asia and the Western
Pacific region.1 Unipolar depressive disorder is a
leading cause of disability. It is the fourth leading
cause of disability-adjusted life years (DALY) in
South-East Asia, and the second leading cause of
DALY in the Western Pacific region.
Previous findings suggest the controversy of
differences in depressive symptomatology among
racial/ethnic groups. For the most parts of such symp-
tomatology, US individuals are likely to respond simi-
larly to the symptoms used for the diagnosis of major
depression across English-speaking racial and ethnic
groups.2 Two large cross-cultural studies have found
similar patterns of depressive syndrome across
countries.3,4 Another small head-to-head study also
reported that the core symptoms of depression are
common in both Japanese andAustralian patients.5 In
contrast, findings from the West suggest that ethnic
differences in depressive symptoms do exist. Such
differences could be observed even in studies carried
out in a single state or country, among immigrants,
and ethnic minorities.6–9 In a cross-study analysis,
Chang et al.10 also found that compared to their US
counterparts, Koreans with major depressive disorder
(MDD) are more likely to have ‘low energy’ and
‘concentration difficulty’, and less likely to express
‘depressedmood’ and ‘thoughts of death’. In addition,
somefield research and anthropological studies found
a greater tendency for Chinese individuals with
depression to complain of somatic symptoms com-
pared to their Western counterparts.11
Few studies have attempted to determine whether
depressive illness, and in particular MDD, shares
similar clinical features across a range of Asian coun-
tries. To our knowledge, only a single quantitative
study has been carried out, comparing Chinese, Japa-
nese, and Korean psychiatric outpatients.12 The sever-
ity of many depressive symptoms (as measured by
the 17-item Hamilton Rating Scale for Depression
[HRSD17]) was found to be different among these
Asian ethnic groups.
The above-mentioned findings suggest that depres-
sive syndrome or its core symptoms may be similar
across ethnic groups, while modest differences can be
found on some symptoms. In addition, such informa-
tion is important for both epidemiological and clini-
cal research. For example, if the preponderance of an
HRSD17 total score was accounted for by somatic fea-
tures in one ethnic group but by mood or cognitive
features in another, adjustments in outcomemeasure-
ment might be necessary. In addition, clinicians
would need to attend to any differing presentations to
ensure that depressive diagnoses are not missed.
Given the above concerns, this study addressed the
following question: Do antidepressant-medication-
free outpatients with depression in China, Korea,
Malaysia/Singapore, Taiwan, and Thailand differ
with regard to clinical and symptom features?
METHODS
Study design and settings
This cross-sectional study examined outpatients with
depressionwhowere attendingpsychiatric practices in
six countries across Asia: China (Beijing and Shang-
hai), Korea (Daegu and Seoul), Malaysia (Kuala
Lumpur)/Singapore, Taiwan (Taoyan and Taipei),
and Thailand (Chiang Mai and Songkhla). It was
designed to provide a preliminary look at the sociode-
mographic and clinical features of individuals who
seek help for MDD that has been clinically diagnosed
using a structured interview based on DSM-IV criteria.
The study was carried out fromOctober 2008 through
March 2010 at 13 study sites. All sites provide tertiary
psychiatric care for the public or private sector. The
study was approved by the Institutional Review Board
or Ethics Committee of each site.
Participants
Participants were prospectively enrolled from outpa-
tients who were seeking psychiatric treatment at the
respective study sites. Individuals who presented for
an intake appointment were approached by a study
coordinator to participate in the study. For those who
chose to participate, study details were explained and
each participant provided written informed consent
prior to study participation.
Evaluable participants for this report had to be
18–65 years of age andmeet DSM-IV criteria forMDD
based on the Mini International Neuropsychiatric
Interview (MINI).13 Exclusion criteria included
unstable medical condition, mood disorder due to
medical conditions and/or substance abuse, psychotic
or bipolar disorder, clinically significant cognitive
impairment, treatment with psychotropic medication
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within the previous month, treatment with a benzo-
diazepine within the previous week, and treatment
with long-acting antipsychotic medication within
the previous 3 months. All other psychiatric and
co-morbid conditions were permitted.
Assessment
Participants completed a case report form in the
presence of the study coordinator. A face-to-face inter-
view was then conducted with the site investigator
before participants met with their treating clinician.
Data collectionwas accomplished in a single visit. The
case report form captured sociodemographic charac-
teristics, including age, sex, ethnicity, education,
marital status, work status, living situation, and
religion. It also included the Symptom Checklist
90-Revised (SCL-90-R).14 The MINI was completed
by trained psychiatrists. The clinical interview gath-
ered information on age at onset of the first major
depressive episode (MDE), duration of index episode,
and number of past psychiatric hospitalizations.
The Montgomery–Asberg Depression Rating Scale
(MADRS)15 was completed during the interview. The
licenses to use the English or validated translations
(Chinese, Korean, Malay, and Thai) of the SCL-90-R
and MADRS were secured from scale proprietors by
Lundbeck Export A/S.
Statistical analysis
Five groups of participants were formed based on
the participants’ country of residence: China,
Taiwan, Malaysia/Singapore, Korea, and Thailand.
These groups were compared with respect to clinical
and depressive symptom features. Potential con-
founding due to differential distributions among
the groups in sociodemographic characteristics were
first identified using χ2-tests. These sociodemo-
graphic characteristics were sex (male/female), age
(18–34, 35–50, 51–65), ethnicity (Chinese, Korean,
Thai, other Asians), marital status (never married,
married/co-habiting, separated/divorced/widowed),
work status (employed, student, homemaker, retired/
unemployed), living situation (living with family
versus not living with family), and religion (no
religion/free thinker, Buddhism, Christianity, other
religions).
ANOVA was performed to compare the groups with
respect to the clinical features of age at onset of
first MDE (in years), duration of index episode (in
months), and the total MADRS score, controlling for
differences in the sociodemographic characteristics.
Except for the variable duration of index episode,
which was transformed in the natural logarithm scale
(to reduce the right skew in the data), all clinical
feature variables were analyzed in their natural units.
For the number of past hospitalizations due to depres-
sion, the variable was first re-coded into 0, 1, and ≥2,
and a log-linear analysis was then carried out to assess
its (partial) association with country of residence,
controlling for confounding sociodemographic
characteristics.
Clinical features that differed among the groups
were controlled for, in addition to confounding
sociodemographic characteristics, in the comparison
of depression presentation. ANCOVA was performed
on individual items of the MADRS, the 13-item
SCL-90-R Depression and the 10-item SCL-90-R
Anxiety Subscales. The SCL-90-R Anxiety Subscale
was also examined because anxiety disorders and
symptoms are strongly co-morbid with major depres-
sive episodes.16 A model with only main effects was
specified.
To address multiplicity in testing, Bonferroni’s cor-
rection was done to retain an overall family-wise
error rate of 5% in each of the MADRS, the SCL-90R-
Depression Subscale and the SCL 90R Anxiety
Subscale. After finding a significant group effect, a
post-hoc pairwise comparison (Bonferroni method)
was used to guide the interpretation of which groups
significantly differed.
Effect sizes (ES) represented by the partial eta-
squared statistic were calculated to complement tests
of statistical significance. A threshold of 0.10 was
taken as the minimum size representing clinical sig-
nificance. The effect sizes of 0.25 and 0.64 were con-
sidered as being moderate, and strong, respectively.17
Statistical analyses were carried out using PASW18
(SPSS, Chicago, IL, USA). The percentage of missing
data did not exceed 4% for any given outcome, so
missing data were excluded from the analyses.
RESULTS
Participant enrollment
A total of 1917 outpatients were screened for eligibil-
ity, of whom 637 (33.2%) were eligible. The reasons
for screen failure were as follows: use of psychotropic
medication (370 patients, 28.9%), failure to meet
the MINI criteria (308 patients, 24.1%), presence of
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psychotic or bipolar disorder (226 patients, 17.7%),
age above 65 years (127 patients, 9.9%), presence of
mood disorders due to medical conditions or sub-
stance abuse (97 patients, 7.6%), age below 18 years
(69 patients, 5.4%), refusal to provide informed
consent (56 patients, 4.4%) or presence of an unstable
or co-morbid medical condition (27 patients, 2.1%).
Of the 637 patients who were confirmed to be
eligible, 556 were enrolled. The remaining patients
were not enrolled for one of the following reasons:
refusal/unwillingness to cooperate (58 patients),
lack of patience to be interviewed (14 patients) or
lack of time to participate in the study (nine patients).
All participants were compensated for their time.
The mean time taken for completion of the self-
administered scales was 35.8 ± 14.1 min, and the
mean time for completionof the face-to-face interview
was 38.1 ± 13.8 min. Nine enrolled patients were
further excluded because they had no current MDE, as
confirmed by the MINI. After the exclusion, all 547
participants included in the analyses met the DSM-IV
diagnosis of MDD with current MDE.
Sociodemographic features
For the entire cohort, the countries of origin were as
follows: 114 participants were from China (20.8%),
101 from Korea (18.5%), 131 from Malaysia/
Singapore (24.0%), 102 from Thailand (18.6%) and
99 fromTaiwan (18.1%) (Table 1).Of all participants,
352 (64.4%) were female. The mean age was 39.6 ±
13.2 years. The ethnic distribution was Chinese:
53.0%; Korean: 18.5%; Thai: 18.6%; Malay: 4.9%;
Indian: 4.4%; and other Asians: 0.5%. The majority
had completed secondary education (75.5%). The
majority were either married or co-habiting (58.2%)
and lived with their families (79.9%). Close to half
were employed (47.5%). The sample was split among
non-believers (39.7%), Buddhists (34.9%), and other
believers (25.4%) (Table 1).
The five country-based groups were comparable
regarding sex (P = 0.226) and living situation (P =
0.110). They differed significantly regarding age, the
percentage that completed secondary education,
marital status, work status, and (as anticipated) in
ethnicity and religion (all P < 0.001). Participants in
China, Taiwan, and Malaysia/Singapore were mostly
between 18 and 34 years of age, whereas participants
in Korea and Thailand were mostly between 50 and
65 years of age (χ2 = 34.199, d.f. = 8, P < 0.001). The
majority of participants completed secondary educa-
tion in all countries. The percentages in China
(83.3%), Taiwan (83.8%), and Malaysia/Singapore
(80.0%) were comparable. Likewise, the percentages
in Korea (63.4%) and Thailand (65.0%) were compa-
rable. The difference between these two groups of
countries was significant (χ2 = 22.641, d.f. = 4,
P < 0.001). Ethnically, participants in China, Taiwan,
Korea, and Thailand were homogeneous; meaning no
less than 99% reported the same ethnic group (e.g.,
Chinese, Korean, Thai). Participants in Malaysia/
Singapore had three dominant groups: Chinese
(59.2%), Malay (20.8%), and Indian (18.5%)
(χ2 = 1114.955, d.f. = 12, P < 0.001). The highest per-
centages of employed individuals (i.e., full-time, part-
time, self-employed) were from Malaysia/Singapore
(63.3%), Thailand (56.3%), and Taiwan (53.7%).
Home-makers constituted a plurality in Korea
(43.6%). The highest percentage of unemployed/
retired participants was reported in China (34.2%)
(χ2 = 83.574, d.f. = 12, P < 0.001). The groups signifi-
cantly differed regarding religion (χ2 = 473.695,
d.f. = 12, P < 0.001), with China having the highest
percentage of non-believers (94.7%), Thailand hav-
ing the highest percentage of believers (100%),
and Malaysia/Singapore being the most diverse
(Table 1).
Clinical features
The MADRS scores ranged from 7 to 51, with a mean
of 29.1 ± 8.14. The mean age at first MDE onset was
36.4 ± 13.3 years (Table 1). The duration of index
episode was highly skewed to the right with a median
(range) of 5.0 (0.5–420.0) months. About 91.4% of
participants (n = 498) reported no previous psychiat-
ric hospitalization. After adjusting for differences in
age, education, marital status, work status, and reli-
gion, significant differences between country groups
were only found for duration of index episode (F =
26.479, d.f.1 = 4, d.f.2 = 528, P < 0.001) and MADRS
depression severity (F = 10.048, d.f.1 = 4, d.f.2 = 528,
P < 0.001). In terms of index episode duration, the
longest median duration was reported by participants
from China: 16.3 (0.5–240.0) months. In terms of
depressive severity, thehighest scoreswere reportedby
participants from Korea (31.2 ± 6.58).
In the comparison of psychiatric symptoms as
measured by the MADRS, SCL-90 Depression
Subscale, and SCL-90 Anxiety Subscales, the seven
variables identified as potential confounders and
were adjusted for accordingly: age, completion of
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secondary education, marital status, work status, reli-
gion, index episode duration, and depressive severity.
Symptom presentation
Montgomery–Asberg Depression Rating Scale
Table 2 summarizes the group comparisons for each
MADRS item. Overall, the most common MADRS
symptoms were ‘reported sadness’ (3.43 ± 1.20)
and ‘reduced sleep’ (3.41 ± 1.61), while the least
common was ‘suicidal thoughts’ (1.95 ± 1.56). The
rest of the symptoms in the order of severity were:
concentration difficulties (3.17 ± 1.30), inability to
feel (3.17 ± 1.30), apparent sadness (3.16 ± 1.14),
inner tension (3.15 ± 1.20), pessimistic thoughts
(2.71 ± 1.42), lassitude (2.69 ± 1.54), and reduced
appetite (2.27 ± 1.67).
After controlling for seven potential confounders
and applying the Bonferroni correction, statistically
significant differences were found between the
country groups for four MADRS symptoms: lassitude
(P < 0.001, ES = 0.131), inner tension (P < 0.001,
ES = 0.080), suicidal thoughts (P < 0.001, ES = 0.041)
and reported sadness (P = 0.004, ES = 0.029). Among
all symptoms and countries, while the most severe
symptom was the reduced sleep in Thai participants
(3.65 ± 0.74), the least severe symptom was also sui-
cidal thoughts in Thai participants (1.36 ± 0.70).
Table 1 Sociodemographic characteristics and clinical features of Asians with major depressive disorder
Attributes Total (n = 547) CN (n = 114) KR (n = 101) MY/SG (n = 131) TH (n = 102) TW (n = 99) P-value
Sociodemographic†
Sex (% female) 64.4 67.5 69.3 56.2 67.0 63.6 χ2 = 5.659, d.f. = 4,
P = 0.226
Age (years) 39.6 (13.2) 37.6 (12.7) 44.8 (14.3) 36.7 (12.0) 41.5 (13.4) 38.5 (12.3) χ2 = 34.199, d.f. = 8,
P < 0.00118–34 40.2 46.5 22.8 51.5 34.0 42.4
35–49 30.2 27.2 32.7 28.5 27.2 36.4
50–65 29.6 26.3 44.6 20.0 38.8 21.1
Education (% completed
secondary education)
75.5 83.3 63.4 80.0 65.0 83.8 χ2 = 22.641, d.f. = 4,
P < 0.001
Ethnicity χ2 = 1114.955,
d.f. = 12,
P < 0.001
Chinese 53.0 100.0 0.0 59.2 0.0 100.0
Korean 18.5 0.0 100.0 0.0 0.0 0.0
Thai 18.6 0.0 0.0 0.0 99.0 0.0
Other Asians 9.9 0.0 0.0 40.8 1.0 0.0
Marital status χ2 = 29.748, d.f. = 8,
P < 0.001Never married 29.3 31.6 23.0 39.2 20.4 29.3
Married/co-habiting 58.2 62.3 64.0 48.5 70.9 47.5
Separated/divorced/
widowed
12.5 6.1 13.0 12.3 8.7 23.2
Work status χ2 = 83.574,
d.f. = 12,
P < 0.001
Employed 47.5 39.5 21.8 62.8 56.9 53.7
Homemaker 20.9 14.0 43.6 10.1 23.5 16.8
Student 12.9 12.3 14.9 13.2 12.7 11.6
Retired/unemployed 18.7 34.2 19.8 13.9 6.9 17.9
Living situation
(% living with family)
79.9 77.2 88.1 74.6 82.5 78.8 χ2 = 7.544, d.f. = 4,
P = 0.110
Religion χ2 = 473.695,
d.f. = 12,
P < 0.001
Non-believers 39.7 94.7 48.5 13.1 0.0 43.4
Buddhists 34.9 3.5 14.9 30.0 89.3 41.4
Christians 13.2 0.9 36.6 16.9 4.9 7.1
Other religions 12.2 0.9 0.0 40.0 5.8 8.1
Clinical
Age at first onset (years),
mean (SD)‡
36.4 (13.3) 34.3 (12.1) 40.6 (14.9) 34.6 (12.3) 37.8 (13.7) 35.7 (12.8) F = 1.382, d.f.1 = 4,
d.f.2 = 527,
P = 0.239
Duration of index episode
(months), mean
(range)§
5.0 (0.5–420.0) 16.3 (0.5–240.0) 5.23 (0.5–240.0) 6.0 (0.5–420.0) 2.0 (0.5–72.0) 3.0 (0.5–48.0) F = 26.479, d.f.1 = 4,
d.f.2 = 528,
P < 0.001
Number of past psychiatric
hospitalizations (%)¶
χ2 = 13.17, d.f. = 8,
P = 0.106
0 91.4 84.2 92.1 95.4 91.3 93.8
1 5.9 11.4 6.9 3.8 3.9 3.1
≥ 2 2.8 4.4 1.0 0.8 4.9 3.1
MADRS total score, mean
(SD)b
29.1 (8.14) 30.8 (9.40) 31.2 (6.58) 28.1 (7.72) 30.5 (6.46) 24.9 (8.53) F = 10.048, d.f.1 = 4,
d.f.2 = 528,
P < 0.001
†Except for mean (SD) age, all sociodemographic data presented as %.
‡Adjusted for sociodemographic differences in age, education, marital status, work status and religion.
§Median (minimum–maximum). Analyzed on a natural logarithmic (ln) scale.
¶Partial association between country and number of hospitalization using log-linear analyses controlling for age, education, marital status, work status and
religion.
CN, China; KR, Korea; MADRS, Montgomery–Asberg Depression Rating Scale; MY/SG, Malaysia/Singapore; TH, Thailand; TW, Taiwan.
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SCL-90-R Depression Subscale
Table 3 summarizes the results with regard to the
SCL-90-R depression items. The unadjusted mean
subscale score was 2.04 ± 0.85 (range: 0.1–3.9). After
controlling for potential confounders, the most
highly endorsed item for the whole sample was
‘feeling blue’ (2.61 ± 0.60) and the least-endorsed
item was ‘feeling of being trapped’ (0.97 ± 0.59).
After the Bonferroni correction, statistically signifi-
cant differences were found in all but four items:
self-blaming (P = 0.062), loss of sexual interest
(P = 0.034), thoughts of ending life (P = 0.009) and
feeling hopeless (P = 0.005). Among all symptoms
and countries, while the most severe symptom was
the feeling blue in Taiwanese (2.82 ± 0.66), the least
severe symptom was the feeling of being trapped in
Chinese (0.33 ± 0.42).
SCL-90-R Anxiety Subscale
Table 4 summarizes the results on the SCL-90-R
anxiety items. The unadjusted mean subscale score
was 2.05 ± 0.85 (range: 0.0–4.0). Compared to the
SCL-90-R depression items, the anxiety items were far
less prominent. The most-endorsed item of the entire
cohort was ‘feeling tense’ (2.37 ± 0.61), and the least-
endorsed item was ‘thoughts and images of a fright-
ening nature’ (1.02 ± 0.48). After the Bonferroni
correction, statistically significant differences were
found in all items except ‘feeling restless’ (P = 0.253)
and ‘suddenly scared’ (P = 0.057).
Among all symptoms and countries, while the
most severe symptom was nervousness in Koreans
(2.67 ± 0.31), the least severe symptom was trem-
bling in Chinese (0.53 ± 0.34).
DISCUSSION
This study of Asian outpatients with MDD revealed
that a large number of depressive and anxious symp-
toms significantly differ across the five country
groups studied. Of the 10 MADRS symptoms/signs,
significant differences were found between the
groups for ‘inner tension’, ‘reported sadness’, ‘lassi-
tude’ and ‘suicidal thoughts’, even after controlling
Table 2. Group comparisons on MADRS items
Items
Unadjusted analyses, mean (SD) Adjusted analyses, mean (SD)†
Total
sample CN KR MY/SG TH TW P-value
Total
sample CN KR MY/SG TH TW P-value
Effect
size
Apparent
sadness
3.16 3.46 3.33 2.95 3.39 2.65 <0.001 3.21 3.40 3.16 3.13 3.32 3.04 0.080 0.016
(1.14) (1.21) (1.08) (1.16) (0.80) (1.21) (0.69) (0.74) (0.52) (0.62) (0.54) (0.69)
Reported
sadness
3.43 3.89 3.80 3.02 3.60 2.90 <0.001 3.42 3.61 3.55 3.16 3.50 3.27 0.004 0.029
(1.20) (1.25) (1.02) (1.17) (0.86) (1.32) (0.87) (0.93) (0.65) (0.76) (0.65) (0.83)
Inner
tension
3.15 2.83 3.08 3.10 3.34 3.47 0.001 3.21 2.75 2.96 3.26 3.25 3.81 <0.001 0.080
(1.20) (1.38) (1.04) (1.09) (0.79) (1.51) (0.67) (0.74) (0.55) (0.62) (0.54) (0.68)
Reduced
sleep
3.41 3.48 3.22 3.34 3.92 3.08 0.002 3.35 3.29 2.97 3.35 3.65 3.51 0.055 0.018
(1.61) (1.63) (1.43) (1.26) (1.62) (2.01) (0.90) (1.01) (0.76) (0.87) (0.74) (0.86)
Reduced
appetite
2.27 2.42 2.31 2.27 2.59 1.67 0.002 2.22 2.36 2.17 2.30 2.16 2.11 0.767 0.003
(1.67) (1.67) (1.34) (1.59) (1.77) (1.85) (1.03) (1.16) (0.87) (1.02) (0.80) (1.07)
Concentration
difficulties
3.17 3.25 2.99 3.23 3.34 2.98 0.161 3.19 3.10 2.82 3.32 3.27 3.44 0.008 0.026
(1.30) (1.67) (1.22) (1.11) (0.94) (1.41) (0.78) (0.93) (0.68) (0.78) (0.63) (0.81)
Lassitude 2.69 2.97 3.22 3.02 2.76 1.24 <0.001 2.68 2.91 3.21 3.02 2.76 1.74 <0.001 0.131
(1.54) (1.61) (1.14) (1.42) (1.29) (1.36) (1.04) (0.95) (0.65) (0.81) (0.66) (0.85)
Inability
to feel
3.17 3.31 3.52 2.91 3.45 2.67 <0.001 3.16 3.07 3.31 2.96 3.30 3.14 0.100 0.015
(1.31) (1.59) (1.08) (1.20) (1.04) (1.34) (0.90) (1.02) (0.70) (0.87) (0.71) (0.88)
Pessimistic
thoughts
2.71 3.01 3.02 2.51 2.53 2.49 0.002 2.74 2.62 2.76 2.61 2.67 3.03 0.067 0.017
(1.42) (1.53) (1.18) (1.31) (1.39) (1.55) (0.91) (1.05) (0.74) (0.87) (0.72) (0.95)
Suicidal
thoughts
1.95 2.20 2.67 1.78 1.54 1.51 <0.001 1.95 2.01 2.40 1.94 1.36 2.02 <0.001 0.041
(1.56) (1.72) (1.39) (1.44) (1.36) (1.63) (0.94) (1.01) (0.72) (0.82) (0.70) (0.92)
Bold font indicates statistical significance.
†Adjusted for age, completion of secondary education, marital status, work status, religion, index episode duration and depressive severity.
Adjusted total and country group means were estimated with covariates evaluated at the following values: age = 39.6, duration of index
episode = 3.2, MADRS score = 29.1.
CN, China; KR, Korea; MADRS, Montgomery–Asberg Depression Rating Scale; MY/SG, Malaysia/Singapore; TH, Thailand; TW, Taiwan.
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for age, completion of secondary education, marital
status, work status, religion, index episode duration,
and depressive severity. Similarly, the SCL-90-R
depression scale revealed a range of differentiating
symptoms. They included feeling lonely, blue,
trapped, worthless, low in energy, and that everything
is an effort; and lacking interest, crying easily and
worrying too much. The MARDRS lassitude item had
the largest effect size (0.131), which was much
smaller than the pre-defined medium one (0.25). The
other items of the MADRS and 13-item SCL-90-R
Depression Subscale had effect sizes lower than the
threshold of minimum clinical significance (<0.10).
Similar results were found with the 10-item SCL-90-R
Anxiety Subscale.
Specifically, our comparison of depressive symp-
toms between the groups found that: (i) mainland
Chinese outpatients are the least likely to self-report
depression; (ii) Taiwanese outpatients are the most
likely to report ‘inner tension’ and the least likely to
report ‘lassitude’; (iii) outpatients in Thailand are the
least likely to express suicidal thoughts; and (iv) out-
patients inMalaysia/Singapore are less likely to report
sadness compared to outpatients in mainland China,
Korea or Thailand.
With regard to depressive symptoms within each
group, we found that: (i) mainland Chinese outpa-
tients most often report ‘feeling low in energy’ or
‘feeling no interest’; (ii) Taiwanese outpatients most
often report ‘feeling blue’ and ‘worrying too much’;
Table 3. Group comparisons on SCL-90R Depression Subscale items
Items
Unadjusted analyses, mean (SD) Adjusted analyses, mean (SD)†
Total
sample CN KR MY/SG TH TW P-value
Total
sample CN KR MY/SG TH TW P-value
Effect
size
Loss of sexual
interest
1.65 1.44 1.86 1.53 1.90 1.59 0.064 1.46 1.05 1.70 1.37 1.58 1.58 0.034 0.020
(1.40) (1.27) (1.42) (1.48) (1.40) (1.38) (0.52) (0.55) (0.47) (0.48) (0.45) (0.49)
Feeling low in
energy
2.48 2.54 2.77 2.69 2.31 2.08 <0.001 2.37 2.20 2.57 2.71 2.17 2.20 0.002 0.033
(1.25) (1.23) (1.20) (1.16) (1.37) (1.18) (0.59) (0.63) (0.48) (0.51) (0.42) (0.60)
Thoughts of
ending life
1.38 1.26 1.90 1.33 1.36 1.15 0.002 1.40 1.02 1.72 1.50 1.33 1.44 0.009 0.026
(1.37) (1.24) (1.49) (1.33) (1.44) (1.27) (0.64) (0.69) (0.53) (0.58) (0.50) (0.68)
Crying easily 1.87 1.35 1.88 2.20 1.89 2.03 <0.001 1.98 1.40 1.91 2.30 2.02 2.28 0.001 0.038
(1.48) (1.38) (1.46) (1.38) (1.52) (1.58) (0.66) (0.61) (0.60) (0.55) (0.52) (0.67)
Feeling being
trapped
1.02 0.49 1.38 1.56 1.01 0.64 <0.001 0.97 0.33 1.44 1.45 0.98 0.66 <0.001 0.094
(1.30) (0.89) (1.43) (1.37) (1.32) (1.12) (0.59) (0.42) (0.41) (0.41) (0.36) (0.44)
Self blaming 1.95 1.83 2.11 1.96 2.24 1.65 0.019 1.89 1.57 1.98 1.86 2.23 1.79 0.062 0.018
(1.34) (1.34) (1.23) (1.43) (1.28) (1.30) (0.59) (0.63) (0.52) (0.53) (0.46) (0.61)
Feeling lonely 2.41 1.94 2.69 2.65 2.62 2.17 <0.001 2.45 1.76 2.81 2.67 2.70 2.29 <0.001 0.068
(1.31) (1.30) (1.25) (1.29) (1.28) (1.29) (0.68) (0.62) (0.59) (0.56) (0.53) (0.69)
Feeling blue 2.67 2.34 2.82 2.76 2.76 2.71 0.016 2.61 2.10 2.69 2.80 2.62 2.82 <0.001 0.045
(1.18) (1.23) (1.07) (1.28) (1.13) (1.10) (0.60) (0.65) (0.50) (0.55) (0.48) (0.66)
Worrying too
much
2.58 2.01 2.81 2.87 2.77 2.44 <0.001 2.44 1.82 2.73 2.71 2.52 2.45 <0.001 0.054
(1.23) (1.26) (1.13) (1.17) (1.23) (1.16) (0.50) (0.41) (0.35) (0.36) (0.31) (0.40)
Feeling no
interest
2.35 2.49 2.54 2.55 1.91 2.20 <0.001 2.19 2.16 2.41 2.49 1.61 2.29 <0.001 0.055
(1.26) (1.26) (1.17) (1.27) (1.31) (1.15) (0.63) (0.67) (0.55) (0.57) (0.47) (0.63)
Feeling
hopeless
2.11 2.07 2.24 2.25 1.99 1.98 0.476 2.01 1.56 2.04 2.30 1.93 2.20 0.005 0.029
(1.46) (1.51) (1.47) (1.42) (1.47) (1.44) (0.74) (0.84) (0.69) (0.69) (0.61) (0.83)
Everything is
effort
1.88 1.64 2.60 1.61 2.34 1.40 <0.001 1.83 1.34 2.40 1.61 2.28 1.53 <0.001 0.074
(1.39) (1.36) (1.24) (1.44) (1.21) (1.30) (0.67) (0.58) (0.43) (0.48) (0.37) (0.56)
Feeling
worthlessness
2.15 1.96 2.62 2.12 2.12 2.04 0.011 2.05 1.44 2.40 2.12 2.10 2.18 <0.001 0.048
(1.41) (1.37) (1.19) (1.40) (1.47) (1.53) (0.74) (0.81) (0.68) (0.65) (0.60) (0.80)
SCL-Depression
Subscale
2.04 1.80 2.33 2.16 2.10 1.85 <0.001 1.98 1.53 2.23 2.15 2.00 1.98 <0.001 0.087
(0.85) (0.86) (0.84) (0.77) (0.84) (0.87) (0.55) (0.60) (0.47) (0.49) (0.43) (0.59)
Bold font indicates statistical significance.
†Adjusted for age, completion of secondary education, marital status, work status, religion, index episode duration and depressive
severity.
Adjusted total and country group means were estimated with covariates evaluated at the following values: age = 39.3, duration of index
episode = 3.2, MADRS score = 29.1.
CN, China; KR, Korea; MADRS, Montgomery–Asberg Depression Rating Scale; MY/SG, Malaysia/Singapore; SCL-90R, Symptom Checklist
90-Revised; TH, Thailand; TW, Taiwan.
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(iii) Malaysian/Singaporean outpatients most often
report ‘feeling blue’, ‘worrying toomuch’, and ‘feeling
low in energy’; (iv) Korean outpatients are likely to
endorse all symptoms, but most often report ‘feeling
lonely’, ‘worrying too much’, ‘feeling blue’, and ‘feel-
ing low in energy’; and (v) outpatients in
Thailandmost often report ‘feeling lonely’, ‘feeling
blue’, and ‘worrying too much’.
Our data on anxiety symptom reporting within
groups suggest that: (i) outpatients in Thailand most
often report ‘feeling tense’; (ii) Taiwanese and Korean
outpatients are similar in their patterns ofmost promi-
nently reporting ‘nervousness’ and ‘feeling tense’, and
(less prominently) ‘feeling fearful’; (iii) Malaysian/
Singaporean outpatients most often report this same
trio of items, but less prominently and in a different
order; and (iv) mainland Chinese outpatients most
often report ‘nervousness’, followed by ‘feeling tense’
and ‘feeling restless’.
The results of this study are relatively similar to
those of the study presented by Nakane et al.12
Although the differences in particular symptoms
among groups might not be the same, both studies
found differences in depressive severity on many
symptoms. Using the HRSD17, Nakane et al. found
that Korean patients with MDD were more likely to
express depressed mood, guilt, agitation, psychic
anxiety, and somatic complaints than were Chinese
and Japanese patients. Chinese patients had more
severe suicidality thandid their Japanese counterparts.
In addition, Japanese patients had more severity with
regard to work and activities, psychomotor retarda-
tion, and somatic complaints than did the Chinese
patients. However, the additional calculation of the
effect sizes in the present studymay have considerable
impact upon the interpretationof our study’s findings.
Although both studies found that the severity ofmany
psychiatric symptoms in Asian patients who have
Table 4. Group comparisons on SCL-90R Anxiety Subscale items
Items
Unadjusted analyses, mean (SD) Adjusted analyses, mean (SD)†
Total
sample CN KR MY/SG TH TW P-value
Total
sample CN KR MY/SG TH TW P-value
Effect
size
02 Nervousness 2.25 2.14 2.72 2.02 1.99 2.47 <0.001 2.23 2.12 2.67 2.04 1.79 2.53 <0.001 0.052
(1.24) (1.30) (1.13) (1.29) (1.21) (1.11) (0.42) (0.37) (0.31) (0.33) (0.25) (0.36)
17 Trembling 1.02 0.38 1.67 1.13 0.99 1.00 <0.001 1.12 0.53 1.67 1.15 0.99 1.25 <0.001 0.085
(1.18) (0.66) (1.16) (1.25) (1.18) (1.18) (0.51) (0.34) (0.28) (0.31) (0.24) (0.34)
23 Suddenly
scared
1.29 0.96 1.32 1.56 1.58 0.96 <0.001 1.42 1.16 1.46 1.57 1.70 1.18 0.057 0.018
(1.30) (1.16) (1.24) (1.38) (1.46) (1.10) (0.49) (0.40) (0.36) (0.43) (0.33) (0.47)
33 Feeling fearful 1.84 1.26 2.16 2.06 1.80 1.93 <0.001 1.81 1.10 2.11 2.06 1.71 2.06 <0.001 0.070
(1.36) (1.23) (1.38) (1.36) (1.40) (1.28) (0.65) (0.64) (0.53) (0.52) (0.46) (0.65)
39 Heart
pounding
1.52 0.99 1.76 1.50 1.78 1.63 <0.001 1.58 1.05 1.86 1.47 1.67 1.83 <0.001 0.040
(1.30) (1.12) (1.34) (1.30) (1.31) (1.31) (0.46) (0.37) (0.32) (0.43) (0.29) (0.36)
57 Feeling tense 2.28 1.81 2.44 2.09 3.06 2.08 <0.001 2.37 1.82 2.48 2.07 3.14 2.33 <0.001 0.077
(1.31) (1.29) (1.24) (1.25) (1.02) (1.38) (0.61) (0.48) (0.35) (0.46) (0.34) (0.49)
72 Spells of terror 1.49 0.87 1.60 1.59 1.93 1.47 <0.001 1.51 0.92 1.63 1.54 1.77 1.71 0.001 0.037
(1.33) (1.13) (1.46) (1.35) (1.18) (1.28) (0.61) (0.57) (0.45) (0.53) (0.40) (0.53)
78 Feeling restless 1.74 1.90 1.61 2.00 1.56 1.52 0.011 1.72 1.80 1.72 1.90 1.46 1.74 0.253 0.010
(1.27) (1.31) (1.26) (1.26) (1.24) (1.22) (0.51) (0.49) (0.44) (0.53) (0.40) (0.46)
80 Feeling
something bad
is to happen
1.49 0.94 1.23 1.69 2.01 1.58 <0.001 1.34 0.63 1.16 1.52 1.80 1.58 <0.001 0.052
(1.36) (1.19) (1.19) (1.34) (1.40) (1.44) (0.59) (0.52) (0.45) (0.43) (0.38) (0.52)
86 Thoughts and
images of a
frightening
nature
1.13 1.11 1.65 0.76 1.19 1.07 <0.001 1.02 0.82 1.48 0.69 1.07 1.06 0.001 0.037
(1.28) (1.15) (1.29) (1.14) (1.30) (1.39) (0.48) (0.45) (0.38) (0.35) (0.33) (0.43)
SCL-Anxiety
Subscale
2.05 1.80 2.33 2.16 2.10 1.85 <0.001 1.61 1.22 1.86 1.64 1.72 1.75 <0.001 0.057
(0.85) (0.86) (0.84) (0.77) (0.84) (0.87) (0.45) (0.44) (0.33) (0.40) (0.31) (0.44)
Bold font indicates statistical significance.
†Adjusted for age, completion of secondary education, marital status, work status, religion, index episode duration and depressive
severity.
Adjusted total and country group means were estimated with covariates evaluated at the following values: age = 39.5, duration of index
episode = 3.2, MADRS score = 29.1.
CN, China; KR, Korea; MADRS, Montgomery–Asberg Depression Rating Scale; MY/SG, Malaysia/Singapore; SCL-90R, Symptom Checklist
90-Revised; TH, Thailand; TW, Taiwan.
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MDD were different among country groups, these
findings might be caused by the large sample sizes.
Taking into account the effect sizes of differences, all
of the symptom differences in the present study are
very small.
As an exploratory study, we did not estimate the
sample size needed. However, by setting the power of
0.80 and the alpha level of 0.05, the power analysis of
the obtained MADRS scores suggested that a sample
size of 27 per country (or group) should be satisfac-
tory. However, the present results need to be con-
firmed through further studies. These findings do,
however, suggest that the psychiatric symptoms in
Asian patients with depression who come from
various ethnic backgrounds are different, though the
differences are not large enough to require criteria or
scale adjustment. Several measures, in particular the
MADRS and the SCL-90-R, appear to be cross-reliable
among Asians with various ethnic backgrounds.
The present study had several limitations. First,
caution should be applied in generalizing the findings
of this study. Theparticipantswere all frompsychiatric
practice sites (public, private) located in urban areas,
so it is unknown to what degree the results apply to
community samples. The exclusion of patients cur-
rently being treated with psychotropic medications
allowed us to have a clear picture of the psychiatric
symptoms in our participants, but this requirement
may have inadvertently led to the exclusion of many
patients commonly seen in typical clinic settings. This
study did not employ random sampling procedures,
and it primarily enrolled patients from tertiary care
settings. In addition, only 33.2% of the screened
patients were included in the study. Second, much of
the similarity across the countries may be due to the
restricted inclusion criteria, which imposed a certain
level of subject uniformity. Third, the MINI is devel-
oped for use in clinical practice. Therefore, it may not
be sensitive to detect mildMDE. Fourth, the sampling
bias was clearly observed in the present sample (e.g.,
age). Although we had adjusted several variables,
some unnoticed characteristics might be overlooked.
Fifth, despite the rigorous methodology set in place
for the translation of scales, nuances may have been
lost in translation. Finally, while the MINI and the
MADRS were used, there was no interrater reliability
established for either measure.
In conclusion, the present study found discernible
differences in a range of depressive and anxiety symp-
toms across psychiatric outpatients drawn from five
Asian countries. These profiles indicate that MDD
patients from the different countries differ with
regard to the likelihood of them suffering from many
depressive and anxiety symptoms. However, these
differences are modest, which suggests that common
psychiatric measures can be used in clinical studies
that enroll Asian outpatients who have depression
and are from different countries.
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